KCTD8

KCTD8 is an auxiliary subunit of GABAB receptors that shapes the kinetics of receptor-evoked signaling in neurons (PMID:21452234). It assembles via its T1 tetramerization domain onto the principal GABAB2 subunit and additionally binds the associated G-protein, while its H1 and H2 homology domains govern desensitization: KCTD8's H1 lacks the T/NFLEQ desensitization motif found in KCTD12-type subunits, and its C-terminal H2 domain sterically inhibits desensitization, so KCTD8-containing receptors generate largely non-desensitizing, slowly deactivating Kir3 currents (PMID:23035119, PMID:25196734). KCTD8 forms homo- and hetero-oligomers (with KCTD12 and KCTD16) through self-interacting T1 and H1 domains, and these tetrameric assemblies diversify receptor deactivation and desensitization kinetics (PMID:28003345). Beyond its GABAB role, KCTD8 directly binds and potentiates the voltage-gated Cav2.3 (R-type) Ca2+ channel independently of GABAB receptor activation, co-localizing with Cav2.3 at presynaptic active zones in the interpeduncular nucleus and bidirectionally modulating transmitter release (PMID:33913808). In habenula cholinergic neurons, KCTD8 (with KCTD12) facilitates axonal expression of GABAB receptors, enabling GABAB-mediated presynaptic excitation of glutamate release and presynaptic Ca2+ entry (PMID:35017224).

1. 2011 Medium

   Establishing that KCTD8 is a bona fide GABAB receptor auxiliary subunit answered whether KCTD proteins are physiological components of native receptors and how they might shape responses.

   Evidence In situ hybridization, immunohistochemistry, and biochemical fractionation in mouse brain

   PMID:21452234

   Open questions at the time

   • Did not resolve which domains mediate receptor binding versus kinetic modulation
   • Mechanism of non-desensitization left undefined
   • Single-lab localization data
2. 2012 High

   Domain dissection answered how KCTD8 produces non-desensitizing responses, mapping receptor binding to T1 and desensitization control to the H1/H2 domains.

   Evidence Domain-swap mutagenesis, chimeric constructs, and electrophysiology in transfected cells

   PMID:23035119

   Open questions at the time

   • Structural basis of H2-mediated steric inhibition not directly visualized
   • Behavior in native neuronal contexts not addressed
3. 2014 Medium

   Direct G-protein engagement studies answered how KCTD8 tunes receptor efficacy and agonist affinity beyond desensitization.

   Evidence [35S]GTPγS binding, BRET between G-protein subunits, and Kir3 recordings in CHO cells and hippocampal neurons

   PMID:25196734

   Open questions at the time

   • Binding interface on the G-protein not mapped
   • Single-lab functional data
4. 2016 High

   Demonstrating KCTD8 hetero-oligomerization answered how a limited set of KCTD subunits generates a continuum of receptor kinetics.

   Evidence Native co-IP in mouse hippocampus, live-cell BRET, and electrophysiology in KCTD-knockout mice

   PMID:28003345

   Open questions at the time

   • Stoichiometry of mixed oligomers in vivo not quantified
   • Functional impact of each combination on specific synapses incompletely defined
5. 2021 High

   Identifying Cav2.3 as a GABAB-independent partner answered whether KCTD8 has functions outside the GABAB receptor, revealing a presynaptic Ca2+ channel modulatory role.

   Evidence Co-IP in heterologous cells, Cav2.3 current recordings, immunofluorescence co-localization, and knockout mouse models

   PMID:33913808

   Open questions at the time

   • Domain of KCTD8 mediating Cav2.3 binding not mapped
   • Mechanism of compensatory upregulation unresolved
6. 2022 High

   Knockout and rescue experiments answered how KCTD8 contributes to receptor trafficking, showing it drives axonal GABAB expression underlying presynaptic excitation.

   Evidence Multiple KCTD knockout lines, electrophysiology, axonal vs. somatic GABAB quantification, and viral overexpression rescue

   PMID:35017224

   Open questions at the time

   • Molecular machinery linking KCTD8 to axonal trafficking not identified
   • Whether trafficking role generalizes beyond habenula neurons unknown
7. 2023 Low

   Interaction mapping tested whether KCTD8 partners with KCTD5, extending the hetero-oligomer network.

   Evidence Co-IP in cell lysates, live-cell BRET, and IP-luminescence domain mapping

   PMID:37762619

   Open questions at the time

   • No functional consequence established for the KCTD8–KCTD5 interaction
   • KCTD5 was the primary focus; KCTD8 specificity secondary
   • Single-lab data
8. 2024 Low

   A tumor-biology study raised a candidate role for KCTD8 in suppressing hepatocellular carcinoma growth via PI3K/AKT.

   Evidence Methylation-specific PCR, flow cytometry, immunoprecipitation, and xenograft models in HCC cell lines

   PMID:39023358

   Open questions at the time

   • No direct binding or catalytic mechanism on the PI3K/AKT axis demonstrated
   • Single-lab finding outside the neuronal context
   • Connection to KCTD8's auxiliary-subunit biology unclear

• How KCTD8 oligomer stoichiometry, G-protein contacts, and Cav2.3 binding are structurally integrated to encode synapse-specific signaling kinetics remains unresolved.
• No high-resolution structure of KCTD8-containing receptor complexes
• Cav2.3-binding interface unmapped
• Trafficking mechanism for axonal GABAB delivery undefined